InvestorsHub Logo
Post# of 253088
Next 10
Followers 49
Posts 3520
Boards Moderated 0
Alias Born 08/24/2005

Re: biocqr post# 196995

Monday, 11/09/2015 9:47:05 AM

Monday, November 09, 2015 9:47:05 AM

Post# of 253088
LOXO > data/scans slide deck...

Clinical safety and activity from a Phase 1
study of LOXO-101, a selective TRKA/B/C inhibitor,
in solid-tumor patients with NTRK gene fusions

https://ir.loxooncology.com/docs/presentations/EORTC_LOXO101.pdf
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.